Credit Agricole’s iHuman IH Stock Holding History

Credit Agricole’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$21K	–	1322
2025 Q4	$21K	Buy	+10,000	New	+$26.5K	﹤0.01%	1238
2025 Q1	$21.2K	Hold	10,000	–	–	﹤0.01%	1195
2024 Q4	$16.9K	Hold	10,000	–	–	﹤0.01%	1219
2024 Q3	$23K	Hold	10,000	–	–	﹤0.01%	1187
2024 Q2	$17.9K	Buy	+10,000	New	+$18.5K	﹤0.01%	1039

Other funds holding IH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Agricole's IH Position: Q1 2026 in Review

Credit Agricole sold out of iHuman (IH) in Q1 2026, closing a stake of 10,000 shares — an estimated $21K sold.

Credit Agricole first reported a position in IH in Q2 2024 and held it in 5 quarters. The position peaked at $23K in Q3 2024. 7 funds tracked by Wall St. Rank hold IH as of Q1 2026.

Credit Agricole reported no remaining iHuman position as of Q1 2026 after selling out during the quarter.
Credit Agricole sold 10,000 iHuman shares in Q1 2026, an estimated $21K.
Credit Agricole first reported a position in iHuman in Q2 2024 and held it in 5 quarters.
Credit Agricole's iHuman position peaked at $23K in Q3 2024.
7 funds tracked by Wall St. Rank held iHuman as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.